Navigation Links
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
Date:12/13/2007

WASHINGTON, Dec. 13 /PRNewswire/ -- Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation. This is a crucial message in a guideline update published online today in the journals of the Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC), and American Heart Association (AHA). To access the "2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention," visit SCAI's official journal, Catheterization and Cardiovascular Interventions, via http://www.scai.org.

Every year, thousands of patients experiencing a heart attack or chest pain (known as angina) undergo percutaneous coronary intervention (PCI), or angioplasty. The procedure is a proven therapy for stopping heart attack and relieving painful symptoms of heart disease that result from arteries narrowed or blocked by the build-up of fatty deposits. The guideline update incorporates findings from research published relatively recently on the role of PCI in the spectrum of care for heart disease patients.

During angioplasty, an interventional cardiologist guides a thin tube (catheter), usually through the groin, to the arteries to reach the blockage. The interventionalist then threads a tiny wire over which a tube carrying a deflated balloon on its tip is advanced to the narrowed segment of the artery. As the tiny balloon is inflated, it compresses the blockage against the inside wall of the artery. This re-opens the artery so blood may again flow freely. To keep the artery open, doctors also may insert an expandable mesh stent - a tiny "scaffold" made of metal -- at the site of the blockage. Drug-eluting stents release medication over time to help keep new tissues from growing and re-blocking the artery.

"For most patients suf
'/>"/>

SOURCE Society for Cardiovascular Angiography and Interventions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI)
2. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
3. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
4. Long-awaited international ethical guidelines for biobank researchers
5. CardioDynamics Provides 2007 Shareholder Meeting Update
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
8. SemBioSys updates Apo AI development program
9. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
10. Biopure Gives Update on Malaysia Joint Venture Discussions
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Involution Studios , a ... a new infographic, Understanding Ebola . The ... designed, easy to follow informative tool for anyone wanting ... symptoms and prevention. , "As the news has spread ... Ebola outbreak represents not only a healthcare crisis with ...
(Date:10/22/2014)... October 22, 2014 Physicians Choice ... cardiovascular pharmacogenetics menu, which enables healthcare providers to ... With PCLS’s evidence-based results, healthcare providers are better ... their therapy, while minimizing risks for adverse drug ... according to the FDA [1] more than 2.2 ...
(Date:10/22/2014)... 22, 2014 Nuvilex, Inc. (OTCQB: NVLX) – ... people worldwide are living with diabetes, with  that number ... The global market for diabetes treatments is approximately $500 ... worldwide died from pancreatic cancer.  Pancreatic cancer is the ... in the United States , and ...
(Date:10/20/2014)... , Oct. 20, 2014 Mapp ... experimental ZMapp™ antibody therapeutic to fight the Ebola ... difficult and time-consuming the production of pharmaceuticals can ... research publisher said that while some may be ... this compound, those with industry knowledge are well ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3
... and the field of polymer science and engineering ... unique properties and processing advantages, which are unattainable ... advances in polymer science and engineering will be ... energy, sustainability, clean water, food preservation, healthcare, informatics, ...
... LAFAYETTE, Ind. ╨ Engineers have discovered details about the behavior ... in manufacturing, diagnostics and other research., ... and surface textures in metals, ceramics and other materials for ... lasers pulse at durations of 100 femtoseconds, or quadrillionths of ...
... Corporation (NYSE: CO ) ("CCBC" or the "Company"), ... China, today announced the results of its 2011 Annual General ... Kong. At the Annual General Meeting, shareholders ... Lu to serve on the Board of Directors until the ...
Cached Biology Technology:Research and education success earns more NSF funding 2Research and education success earns more NSF funding 3Research could improve laser-manufacturing technique 2China Cord Blood Corporation Announces Results of 2011 Annual General Meeting 2
(Date:10/16/2014)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market announces ... the Smart Wallet, at the 13 th annual ... global conference on the intersection of technology and the ... , founder and publisher of the Strategic News Service™, ...
(Date:10/15/2014)... is spreading rapidly and to an unexpected extent. The ... past and the virus shows a new disease dynamic ... For this reason, the German National Academy of Sciences ... Engineering, and the Union of the German Academies of ... Ebola epidemic today. , In the statement the academies ...
(Date:10/14/2014)... cancer tumors scavenge and hoard copper that is an ... be a fatal weakness. , Researchers at Duke ... cells by delivering a trove of copper along with ... with the mineral, leaving non-cancer cells healthy. , The ... for other uses, could soon be tested in clinical ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Prostate cancer's penchant for copper may be a fatal flaw 2
... the National Institutes of Health (NIH) have determined the ... Borrelia burgdorferi , the bacteria that cause Lyme disease. ... how genetic variations among strains may result in different ... most common tickborne disease in North America. The wealth ...
... 2010 - Alcohol is one of the most commonly ... likely to develop alcoholism as women. Until now, the ... remained unclear. A new study published in Biological ... factor. Researchers from Columbia and Yale studied male and ...
... understand the effects of climate change on the microbial ... and the tundra in Alaska, a University of Oklahoma ... of Energy grant. According to Jizhong Zhou, OU ... Institute for Environmental Genomics, the results of these studies ...
Cached Biology News:Why are men more susceptible to alcoholism? 2
...
Mouse anti-JNK (PT183/185) Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Acetyl CoA Carboxylase Antibody...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Biology Products: